Evidence map›Paper›PMID 25320326›Full record

ArticleJournal of virology2015

Proinflammatory effects of interferon gamma in mouse adenovirus 1 myocarditis.

Mary K McCarthy, Megan C Procario, Nele Twisselmann, J Erby Wilkinson, Ashley J Archambeau, Daniel E Michele, Sharlene M Day, Jason B Weinberg

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Interferon gamma signaling drives cardiac metabolic rewiring.bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Innate and adaptive immunity in acute myocarditis.International journal of cardiology · 2024
    Review
  9. Infectious factors in myocarditis: a comprehensive review of common and rare pathogens.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2024
    Review
  10. Article
  11. Interferons and interferon-related pathways in heart disease.Frontiers in cardiovascular medicine · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Reduction of CD11bOncoimmunology · 2020
    Article
  18. Article
  19. Adenovirus targets transcriptional and posttranslational mechanisms to limit gap junction function.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mary K McCarthyDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.
Megan C ProcarioDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA.
Nele TwisselmannDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA.
J Erby WilkinsonUnit for Laboratory Animal Research, University of Michigan, Ann Arbor, Michigan, USA Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Ashley J ArchambeauDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA.
Daniel E MicheleDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA.
Sharlene M DayDivision of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Jason B WeinbergDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA jbwein@umich.edu.
University of Michigan–Ann Arbor · US

Funding

Regulation of Proteasome Function in CardiomyopathiesR01HL093338 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAY, SHARLENE M · 2009 to 2013
$1.9M
Adenovirus myocarditis: defining host factors contributing to pathogenesisR21AI103452 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEINBERG, JASON BRICE · 2013 to 2014
$414k
NHLBI NIH HHS R01 HL093338NIAID NIH HHS R21 AI103452
6 · The paper itself

Abstract

unlabelledAdenoviruses are frequent causes of pediatric myocarditis. Little is known about the pathogenesis of adenovirus myocarditis, and the species specificity of human adenoviruses has limited the development of animal models, which is a significant barrier to strategies for prevention or treatment. We have developed a mouse model of myocarditis following mouse adenovirus 1 (MAV-1) infection to study the pathogenic mechanisms of this important cause of pediatric myocarditis. Following intranasal infection of neonatal C57BL/6 mice, we detected viral replication and induction of interferon gamma (IFN-γ) in the hearts of infected mice. MAV-1 caused myocyte necrosis and induced substantial cellular inflammation that was composed predominantly of CD3(+) T lymphocytes. Depletion of IFN-γ during acute infection reduced cardiac inflammation in MAV-1-infected mice without affecting viral replication. We observed decreased contractility during acute infection of neonatal mice, and persistent viral infection in the heart was associated with cardiac remodeling and hypertrophy in adulthood. IFN-γ is a proinflammatory mediator during adenovirus-induced myocarditis, and persistent adenovirus infection may contribute to ongoing cardiac dysfunction. IMPORTANCE: Studying the pathogenesis of myocarditis caused by different viruses is essential in order to characterize both virus-specific and generalized factors that contribute to disease. Very little is known about the pathogenesis of adenovirus myocarditis, which is a significant impediment to the development of treatment or prevention strategies. We used MAV-1 to establish a mouse model of human adenovirus myocarditis, providing the means to study host and pathogen factors contributing to adenovirus-induced cardiac disease during acute and persistent infection. The MAV-1 model will enable fundamental studies of viral myocarditis, including IFN-γ modulation as a therapeutic strategy.

Indexed as

AnimalsCD3 ComplexFemaleInterferon-gammaMaleMastadenovirusMice, Inbred C57BLMonocytesMyocarditisMyocardiumT-LymphocytesVirus ReplicationCD3 ComplexInterferon-gamma

Identifiers

PMID25320326
PMCPMC4301126
OpenAlexW2021743113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.